FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
Ahmad Antar, Zaher K. Otrock, Elias Jabbour, Mohamad Mohty, Ali Bazarbachi
Topics & Concepts
MidostaurinMyeloid leukemiaMedicineSorafenibFms-Like Tyrosine Kinase 3Tyrosine kinaseOncologyTyrosine-kinase inhibitorLeukemiaInternal medicinePharmacologyCancer researchCancerBiologyMutationGeneBiochemistryReceptorHepatocellular carcinomaAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research